167 related articles for article (PubMed ID: 37228412)
1. APOE as potential biomarkers of moyamoya disease.
Wu H; Xu J; Sun J; Duan J; Xiao J; Ren Q; Zhou P; Yan J; Li Y; Xiong X; Zeng E
Front Neurol; 2023; 14():1156894. PubMed ID: 37228412
[TBL] [Abstract][Full Text] [Related]
2. Identification of immune-infiltrated hub genes as potential biomarkers of Moyamoya disease by bioinformatics analysis.
Jin F; Duan C
Orphanet J Rare Dis; 2022 Feb; 17(1):80. PubMed ID: 35197088
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive molecular analyses of an autoimmune-related gene predictive model and immune infiltrations using machine learning methods in moyamoya disease.
Li S; Han Y; Zhang Q; Tang D; Li J; Weng L
Front Mol Biosci; 2022; 9():991425. PubMed ID: 36605987
[No Abstract] [Full Text] [Related]
4. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis reveals the landscape of immune cell infiltration and novel immune-related biomarkers in moyamoya disease.
Cao L; Ai Y; Dong Y; Li D; Wang H; Sun K; Wang C; Zhang M; Yan D; Li H; Liang G; Yang B
Front Genet; 2023; 14():1101612. PubMed ID: 37265961
[No Abstract] [Full Text] [Related]
6. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.
Cheng Q; Chen X; Wu H; Du Y
J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Expression in Circulating Leukocytes and Bioinformatic Analysis of Patients With Moyamoya Disease.
Kang K; Shen Y; Zhang Q; Lu J; Ju Y; Ji R; Li N; Wu J; Yang B; Lin J; Liang X; Zhang D; Zhao X
Front Genet; 2022; 13():816919. PubMed ID: 35669195
[No Abstract] [Full Text] [Related]
8. Identifying hub genes and miRNAs in Crohn's disease by bioinformatics analysis.
Sun Y; Cai D; Hu W; Fang T
Front Genet; 2022; 13():950136. PubMed ID: 36118873
[No Abstract] [Full Text] [Related]
9. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.
Zhao J; He K; Du H; Wei G; Wen Y; Wang J; Zhou X; Wang J
PeerJ; 2022; 10():e13932. PubMed ID: 36157062
[TBL] [Abstract][Full Text] [Related]
10. Identification of Hub Genes in the Pathogenesis of Ischemic Stroke Based on Bioinformatics Analysis.
Yang X; Yan S; Wang P; Wang G
J Korean Neurosurg Soc; 2022 Sep; 65(5):697-709. PubMed ID: 35577542
[TBL] [Abstract][Full Text] [Related]
11. Integrative bioinformatics approaches for identifying potential biomarkers and pathways involved in non-obstructive azoospermia.
Hu T; Luo S; Xi Y; Tu X; Yang X; Zhang H; Feng J; Wang C; Zhang Y
Transl Androl Urol; 2021 Jan; 10(1):243-257. PubMed ID: 33532314
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
Qin X; Song Y
Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
[TBL] [Abstract][Full Text] [Related]
13. Identification of key miRNAs and their targets in peripheral blood mononuclear cells of IgA nephropathy using bioinformatics analysis.
Liu L; Yang Y; Yu D
Medicine (Baltimore); 2021 Jul; 100(26):e26495. PubMed ID: 34190177
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Apolipoprotein-E and Apolipoprotein-J in Moyamoya Disease-A Proteome Analysis of Cerebrospinal Fluid.
Kashiwazaki D; Uchino H; Kuroda S
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2981-2987. PubMed ID: 28843803
[TBL] [Abstract][Full Text] [Related]
15. Serum miRNA signature in Moyamoya disease.
Dai D; Lu Q; Huang Q; Yang P; Hong B; Xu Y; Zhao W; Liu J; Li Q
PLoS One; 2014; 9(8):e102382. PubMed ID: 25093848
[TBL] [Abstract][Full Text] [Related]
16. Identification of keygenes, miRNAs and miRNA-mRNA regulatory pathways for chemotherapy resistance in ovarian cancer.
Wang W; Zhang W; Hu Y
PeerJ; 2021; 9():e12353. PubMed ID: 34820170
[TBL] [Abstract][Full Text] [Related]
17. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
Yang Q; Li K; Li X; Liu J
Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
[No Abstract] [Full Text] [Related]
18. Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis.
Hu W; Fang T; Chen X
Front Genet; 2022; 13():914384. PubMed ID: 35719390
[No Abstract] [Full Text] [Related]
19. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
20. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
Zuo L; Li X; Tan Y; Zhu H; Xiao M
J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
